Reports Q4 revenue $352.49M vs. $308.68M last year. Reports Q4 adjusted EPS (23c).
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CURLF:
- Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results
- Here’s What You Missed in Cannabis This Week
- NJ reversal a win for Curaleaf and other MSOs, says Alliance Global Partners
- Curaleaf spikes over 7% after NJ CRC Board reverses, okays adult use renewals
- Curaleaf says NJ CRC Board reverses, fully approves adult use renewals